Pharmafile Logo

toothbrush

- PMLiVE

FDA forces Achillion to delay hepatitis C programme

Abnormal liver functions detected in some patients taking sovaprevir

- PMLiVE

Setback for Merck & Co as FDA knocks back insomnia drug

US regulator asks for company to file for approval of a lower starting dose of suvorexant

- PMLiVE

US increases pressure on India over generics industry

Follows complaints from Pfizer about the country’s patent laws

- PMLiVE

Icon promotes Brendan Buckley to chief medical officer

In his new role he will serve as the CRO's lead medical expert

- PMLiVE

Rebooting the innovation engine

How can the industry transform the efficacy of its R&D teams so they can do more with less?

- PMLiVE

GSK’s personalised cancer drug Tafinlar set for European approval

Regulatory advisors recommend the melanoma drug be licensed

- PMLiVE

Onyx rejects $10bn takeover bid from Amgen

Says offer is too low, but doesn't rule out a deal

- PMLiVE

First mAb biosimilars set for European approval

Celltrion and Hospira's versions of J&J's blockbuster Remicade recommended by CHMP

Sanofi reception

Sanofi wins Japanese approval for diabetes drug Lyxumia

Becomes first treatment of its class licensed in combination with basal insulin

- PMLiVE

Fresenius sells biotech business

Germany company's biotechnology arm picked up by Neopharm owners

- PMLiVE

Edward Hodgkin elected chair of UK biotech association

He will take up his new role at the BIA in October

mHealth: patients open to app prescriptions

Study suggests patients want to use technology to self-manage

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links